Gharda Scientific Research Foundation Profile
Key Indicators
- Company Age 47 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 160.70%
(FY 2020)
- Profit 115.85%
(FY 2020)
- Ebitda 6.62%
(FY 2020)
- Net Worth 3.99%
(FY 2020)
- Total Assets 1.54%
(FY 2020)
About Gharda Scientific Research Foundation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Percy Kavasmaneck, Anil Kakodkar, Keki Gharda, and One other member serve as directors at the Company.
- CIN/LLPIN
U74210MH1977GAT019689
- Company No.
019689
- Company Classification
Private Limited Guarantee & Association
- Incorporation Date
08 Jun 1977
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gharda Scientific Research Foundation?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Percy Kavasmaneck  | Director | 19-Jun-2017 | Current |
Anil Kakodkar  | Director | 06-Jun-2013 | Current |
| Keki Gharda | Director | 08-Jun-1977 | Current |
| Raghunath Mashelkar | Director | 29-Jul-2010 | Current |
Financial Performance and Corporate Structure Insights of Gharda Scientific Research Foundation.
Gharda Scientific Research Foundation, for the financial year ended 2020, experienced significant growth in revenue, with a 160.7% increase. The company also saw a substantial improvement in profitability, with a 115.85% increase in profit. The company's net worth moved up by a moderate rise of 3.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gharda Scientific Research Foundation?
Unlock access to Gharda Scientific Research Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
International Longevity Centre- IndiaActive 16 years 6 monthsRaghunath Mashelkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gharda Scientific Research Foundation?
Gharda Scientific Research Foundation has a workforce of 26 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gharda Scientific Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gharda Scientific Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
